Option Care Health (NASDAQ:OPCH) Hits New 52-Week Low – Time to Sell?

Option Care Health, Inc. (NASDAQ:OPCH)’s share price hit a new 52-week low on Tuesday . The stock traded as low as $21.54 and last traded at $21.54, with a volume of 3973 shares trading hands. The stock had previously closed at $21.74.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on OPCH. Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. JMP Securities increased their target price on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research report on Monday, September 30th. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the stock from $38.00 to $27.00 in a report on Monday, November 4th. Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their price objective for the company from $38.00 to $26.00 in a report on Thursday, October 31st. Finally, Truist Financial cut their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, Option Care Health currently has an average rating of “Moderate Buy” and an average price target of $30.83.

Option Care Health Trading Up 0.3 %

The stock has a market capitalization of $3.72 billion, a PE ratio of 18.39, a P/E/G ratio of 2.27 and a beta of 1.32. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company’s 50 day moving average price is $27.98 and its two-hundred day moving average price is $29.21.

Insiders Place Their Bets

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of Option Care Health stock in a transaction dated Friday, November 8th. The shares were acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.64% of the company’s stock.

Institutional Trading of Option Care Health

Several institutional investors have recently made changes to their positions in OPCH. TD Private Client Wealth LLC raised its position in Option Care Health by 21.4% in the third quarter. TD Private Client Wealth LLC now owns 5,723 shares of the company’s stock valued at $179,000 after purchasing an additional 1,007 shares during the period. Teachers Retirement System of The State of Kentucky increased its position in shares of Option Care Health by 4.1% during the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 390,921 shares of the company’s stock worth $12,236,000 after purchasing an additional 15,357 shares during the last quarter. Barclays PLC raised its holdings in Option Care Health by 180.1% in the 3rd quarter. Barclays PLC now owns 310,194 shares of the company’s stock valued at $9,708,000 after buying an additional 199,454 shares during the period. Pier Capital LLC raised its holdings in Option Care Health by 88.4% in the 3rd quarter. Pier Capital LLC now owns 231,884 shares of the company’s stock valued at $7,258,000 after buying an additional 108,783 shares during the period. Finally, Orion Portfolio Solutions LLC lifted its position in Option Care Health by 2.3% in the third quarter. Orion Portfolio Solutions LLC now owns 28,232 shares of the company’s stock valued at $884,000 after buying an additional 636 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.